Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia-Reference-Cited by-同舟云学术

Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia

Published:2016-08 Issue:2 Volume:128 Page:261-269
ISSN:0029-7844
Container-title:Obstetrics & Gynecology
language:en
Short-container-title:

Author:

Zeisler Harald,Llurba Elisa,Chantraine Frédéric,Vatish Manu,Staff Anne Cathrine,Sennström Maria,Olovsson Matts,Brennecke Shaun P.,Stepan Holger,Allegranza Deirdre,Dinkel Carina,Schoedl Maria,Dilba Peter,Hund Martin,Verlohren Stefan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology

Reference11 articles.

1. Angiogenesis-related biomarkers (sFlt-1/PLGF) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration;Herraiz;Int J Mol Sci,2015

2. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia;Maynard;J Clin Invest,2003

3. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia;Levine;N Engl J Med,2006

4. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia;Zeisler;N Engl J Med,2016

5. Medically indicated–iatrogenic prematurity;Wong;Clin Perinatol,2011

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the use of angiogenic biomarkers for the management of preeclampsia and fetal growth restriction improve outcomes?: Challenging the current status quo;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

2. Immunoexpression of Placental Growth Factor (PlGF) and Soluble FMS-like Tyrosine Kinase 1 (sFlt-1) in the Placental Bed of Preeclamptic women of African ancestry living with HIV infection;2024-07-11

3. Ratio of soluble fms–like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with preeclampsia: a letter;American Journal of Obstetrics and Gynecology;2024-07

4. Trends in antenatal corticosteroid administration: did our timing improve?;Journal of Perinatal Medicine;2024-04-26

5. Longitudinal 8-Epi-Prostaglandin F2-Alpha and Angiogenic Profile Mediator Evaluation during Pregnancy in Women with Suspected or Confirmed Pre-eclampsia;Biomedicines;2024-02-14